Ameritas Investment Partners’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,457
| Closed | -$548K | – | 3075 |
|
|
2019
Q4 | $548K | Buy |
6,457
+173
| +3% | +$11.5K | 0.02% | 727 |
|
|
2019
Q3 | $314K | Buy |
6,284
+473
| +8% | +$18.9K | 0.01% | 867 |
|
|
2019
Q2 | $212K | Hold |
5,811
| – | – | 0.01% | 1029 |
|
|
2019
Q1 | $162K | Hold |
5,811
| – | – | 0.01% | 1173 |
|
|
2018
Q4 | $111K | Hold |
5,811
| – | – | 0.01% | 1307 |
|
|
2018
Q3 | $174K | Hold |
5,811
| – | – | 0.01% | 1179 |
|
|
2018
Q2 | $213K | Sell |
5,811
-247
| -4% | -$8.03K | 0.01% | 1036 |
|
|
2018
Q1 | $200K | Hold |
6,058
| – | – | 0.01% | 1068 |
|
|
2017
Q4 | $166K | Hold |
6,058
| – | – | 0.01% | 1190 |
|
|
2017
Q3 | $222K | Hold |
6,058
| – | – | 0.01% | 1006 |
|
|
2017
Q2 | $230K | Buy |
6,058
+243
| +4% | +$10.8K | 0.01% | 986 |
|
|
2017
Q1 | $284K | Buy |
+5,815
| New | +$265K | 0.01% | 902 |
|
|
2016
Q4 | – | Sell |
-5,815
| Closed | -$219K | – | 1285 |
|
|
2016
Q3 | $219K | Buy |
+5,815
| New | +$219K | 0.01% | 973 |
|
|
2014
Q3 | – | Sell |
-29,200
| Closed | -$848K | – | 1106 |
|
|
2014
Q2 | $848K | Hold |
29,200
| – | – | 0.06% | 343 |
|
|
2014
Q1 | $829K | Buy |
29,200
+23,743
| +435% | +$786K | 0.07% | 346 |
|
|
2013
Q4 | $211K | Buy |
+5,457
| New | +$195K | 0.02% | 956 |
|
Other funds holding MDCO
Ameritas Investment Partners's MDCO Position: Q1 2020 in Review
Ameritas Investment Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 6,457 shares — an estimated $548K sold.
Ameritas Investment Partners first reported a position in MDCO in Q4 2013 and held it in 16 quarters. The position peaked at $848K in Q2 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Ameritas Investment Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Ameritas Investment Partners sold 6,457 Medicines Co shares in Q1 2020, an estimated $548K.
- Ameritas Investment Partners first reported a position in Medicines Co in Q4 2013 and held it in 16 quarters.
- Ameritas Investment Partners's Medicines Co position peaked at $848K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Ameritas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.